These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 14760062)

  • 21. Identification and functional analysis of single nucleotide polymorphism in the tandem repeat sequence of thymidylate synthase gene.
    Kawakami K; Watanabe G
    Cancer Res; 2003 Sep; 63(18):6004-7. PubMed ID: 14522928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single nucleotide polymorphism in the 5' tandem repeat sequences of thymidylate synthase gene predicts for response to fluorouracil-based chemotherapy in advanced colorectal cancer patients.
    Marcuello E; Altés A; del Rio E; César A; Menoyo A; Baiget M
    Int J Cancer; 2004 Dec; 112(5):733-7. PubMed ID: 15386371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thymidylate synthase expression and genotype have no major impact on the clinical outcome of colorectal cancer patients treated with 5-fluorouracil.
    Vignoli M; Nobili S; Napoli C; Putignano AL; Morganti M; Papi L; Valanzano R; Cianchi F; Tonelli F; Mazzei T; Mini E; Genuardi M
    Pharmacol Res; 2011 Sep; 64(3):242-8. PubMed ID: 21536130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor thymidylate synthase 1494del6 genotype as a prognostic factor in colorectal cancer patients receiving fluorouracil-based adjuvant treatment.
    Dotor E; Cuatrecases M; Martínez-Iniesta M; Navarro M; Vilardell F; Guinó E; Pareja L; Figueras A; Molleví DG; Serrano T; de Oca J; Peinado MA; Moreno V; Germà JR; Capellá G; Villanueva A
    J Clin Oncol; 2006 Apr; 24(10):1603-11. PubMed ID: 16575011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thymidylate synthase gene promoter polymorphisms are associated with TSmRNA expressions but not with microsatellite instability in colorectal cancer.
    Calascibetta A; Cabibi D; Martorana A; Sanguedolce G; Rausa L; Feo S; Dardanoni G; Sanguedolce R
    Anticancer Res; 2004; 24(6):3875-80. PubMed ID: 15736425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphism of thymidylate synthase gene associated with its protein expression in human colon cancer.
    Yu KH; Wang WX; Ding YM; Li H; Wang ZS
    World J Gastroenterol; 2008 Jan; 14(4):617-21. PubMed ID: 18203297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphic tandem repeats in the thymidylate synthase gene is associated with its protein expression in human gastrointestinal cancers.
    Kawakami K; Omura K; Kanehira E; Watanabe Y
    Anticancer Res; 1999; 19(4B):3249-52. PubMed ID: 10652619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression.
    Kawakami K; Salonga D; Park JM; Danenberg KD; Uetake H; Brabender J; Omura K; Watanabe G; Danenberg PV
    Clin Cancer Res; 2001 Dec; 7(12):4096-101. PubMed ID: 11751507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic copy number changes affecting the thymidylate synthase (TYMS) gene in cancer: a model for patient classification to aid fluoropyrimidine therapy.
    Brody JR; Hucl T; Gallmeier E; Winter JM; Kern SE; Murphy KM
    Cancer Res; 2006 Oct; 66(19):9369-73. PubMed ID: 17018589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of thymidylate synthase polymorphisms in rectal cancer patients treated with neoadjuvant chemoradiotherapy.
    Arrazubi V; Suárez J; Guerrero D; Gómez M; Viúdez A; Arias F; Balén E; Vera R
    Colorectal Dis; 2013 Apr; 15(4):428-35. PubMed ID: 22958523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations between polymorphisms in the thymidylate synthase gene, the expression of thymidylate synthase mRNA and the microsatellite instability phenotype of colorectal cancer.
    Merkelbach-Bruse S; Hans V; Mathiak M; Sanguedolce R; Alessandro R; Rüschoff J; Büttner R; Houshdaran F; Gullotti L
    Oncol Rep; 2004 Apr; 11(4):839-43. PubMed ID: 15010882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic heterogeneity of variable number tandem repeats in thymidylate synthase gene in colorectal cancer patients.
    Agostini M; Pulciarelli S; Bertorelle R; Calandra P; Villani F; Lise M; Nitti D
    Int J Biol Markers; 2004; 19(4):332-6. PubMed ID: 15646842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thymidylate synthase enhancer region polymorphism not related to susceptibility to acute lymphoblastic leukemia in the Kashmir population.
    Nazki FH; Masood A; Banday MA; Bhat A; Ganai BA
    Genet Mol Res; 2012 Apr; 11(2):906-17. PubMed ID: 22576918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination of polymorphisms within 5' and 3' untranslated regions of thymidylate synthase gene modulates survival in 5 fluorouracil-treated colorectal cancer patients.
    Fernández-Contreras ME; Sánchez-Hernández JJ; González E; Herráez B; Domínguez I; Lozano M; García De Paredes ML; Muñoz A; Gamallo C
    Int J Oncol; 2009 Jan; 34(1):219-29. PubMed ID: 19082493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapy.
    Graziano F; Ruzzo A; Loupakis F; Santini D; Catalano V; Canestrari E; Maltese P; Bisonni R; Fornaro L; Baldi G; Masi G; Falcone A; Tonini G; Giordani P; Alessandroni P; Giustini L; Vincenzi B; Magnani M
    Br J Cancer; 2008 Sep; 99(5):716-21. PubMed ID: 18728661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative analysis of thymidylate synthase at the protein, mRNA, and DNA levels as prognostic markers in colorectal adenocarcinoma.
    Ren DN; Kim IY; Koh SB; Chang SJ; Eom M; Yi SY; Seong SH; Kim MD; Bronner MP; Cho MY
    J Surg Oncol; 2009 Dec; 100(7):546-52. PubMed ID: 19722231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphism in the thymidylate synthase promoter enhancer region and risk of colorectal adenomas.
    Chen J; Kyte C; Chan W; Wetmur JG; Fuchs CS; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2247-50. PubMed ID: 15598787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thymidylate synthase gene polymorphism predicts disease free survival in stage II-III rectal adenocarcinoma patients receiving adjuvant 5-FU-based chemotherapy.
    Su X; Li S; Zhang H; Xiao H; Chen C; Wang G
    Chin Clin Oncol; 2019 Jun; 8(3):28. PubMed ID: 30823845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacogenetic Analysis of the UK MRC (Medical Research Council) MAGIC Trial: Association of Polymorphisms with Toxicity and Survival in Patients Treated with Perioperative Epirubicin, Cisplatin, and 5-fluorouracil (ECF) Chemotherapy.
    Smyth E; Zhang S; Cunningham D; Wotherspoon A; Soong R; Peckitt C; Valeri N; Fassan M; Rugge M; Okines A; Allum W; Stenning S; Nankivell M; Langley R; Tan P
    Clin Cancer Res; 2017 Dec; 23(24):7543-7549. PubMed ID: 28972045
    [No Abstract]   [Full Text] [Related]  

  • 40. G>C SNP of thymidylate synthase with respect to colorectal cancer.
    Gusella M; Padrini R
    Pharmacogenomics; 2007 Aug; 8(8):985-96. PubMed ID: 17716232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.